These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 28976051)

  • 21. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.
    Jordan N; Chaib A; Sangle S; Tungekar F; Sabharwal T; Abbs I; Khamashta M; D'Cruz D
    Arthritis Care Res (Hoboken); 2014 May; 66(5):725-31. PubMed ID: 24127353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
    Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
    Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pelvic deep venous thrombosis mimicking lower limb cellulitis in systemic lupus erythematosus-associated antiphospholipid syndrome.
    Wang CR; Lee CH
    Lupus; 2022 Apr; 31(5):613-618. PubMed ID: 35293251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
    Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
    Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
    Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
    Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
    Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
    J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ
    Pathologe; 1996 Nov; 17(6):405-16. PubMed ID: 9082361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus: a case-based review.
    Garcia-Diaz J; Escudero-Salamanca M; Alvarez-Santana R; Espinola-Zavaleta N
    Future Cardiol; 2021 Sep; 17(6):985-990. PubMed ID: 33140653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome.
    Oki H; Aoki T; Saito K; Yamashita Y; Hanamiya M; Hayashida Y; Tanaka Y; Korogi Y
    Eur J Radiol; 2012 Jun; 81(6):1335-9. PubMed ID: 21501937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment.
    Diószegi Á; Tarr T; Nagy-Vincze M; Nánásy-Vass M; Veisz R; Bidiga L; Dezső B; Balla J; Szodoray P; Szekanecz Z; Soltész P
    Lupus; 2018 Aug; 27(9):1552-1558. PubMed ID: 29635999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catastrophic Anti-Phospholipid Syndrome in Systemic Lupus Erythematosus: A Tsunami in the Ocean.
    Dorji T; Hegde A; Asturkar V; Yangzom S; Bhanu K
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective immunoglobulin M deficiency complicated by systemic lupus erythematosus and antiphospholipid syndrome: a case report and review of literature.
    Shimamura Y; Maeda T; Abe K; Ogawa Y; Takizawa H
    CEN Case Rep; 2021 Aug; 10(3):435-441. PubMed ID: 33616883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature.
    Stanescu C; Andronesi AG; Jurcut C; Gherghiceanu M; Vornicu A; Burcea FA; Andronesi TD; Lupusoru GE; Iliuta L; Sorohan BM; Obrisca B; Ismail G
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus.
    Tarr T; Lakos G; Bhattoa HP; Szegedi G; Shoenfeld Y; Kiss E
    Lupus; 2007; 16(5):324-8. PubMed ID: 17576733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
    Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
    Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.